vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026 
How Braden Business Systems Use Auvik SaaS Management
to Identify, Secure, and Manage SaaS Sprawl About Braden Business Systems & Jon Fitzryk Since 1989, Braden Business Systems has...
Efficient Network Management: A Dive into Auvik Network Management’s Robust Features
In today's fast-paced digital world, efficient and effective network management has become more important than ever. With businesses relying heavily...
vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systemsHIGH POINT, N.C., Oct. 10,...
Corza Medical Launches Expanded Blink Single-Use Custom Packs and First-of-Its-Kind Microsurgical Knife Manufacturing Process
BOULDER, Colo., Oct. 10, 2026 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch...
LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress
NEW YORK, Oct. 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines...
Haag-Streit USA and Marco Lombart launch Octopus 910 in the US at AAO 2026 in New Orleans
MASON, Ohio, Oct. 10, 2026 /PRNewswire/ -- Haag-Streit USA and Marco Lombart, an Advancing Eyecare company and the exclusive U.S. distributor of...
RingConn Receives FDA 510(k) Clearance for Non-Invasive Blood Oxygen (SpO2) Measurement
Shenzhen, China, Oct. 10, 2026 /PRNewswire/ -- Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart...
MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
Furoscix ReadyFlow™ Furoscix ReadyFlow™ Furoscix ReadyFlow™ Furoscix ReadyFlow™ New analyses on Furoscix ReadyFlow PK/PD performance delivered via an autoinjector demonstrated...
Integra Announces Pricing of Senior Secured Notes
PRINCETON, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) (the “Company”) today announced the pricing of...
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines...
Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering
Singapore, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today closed its registered direct...
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
SINGAPORE, Oct. 09, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (the “Company”) (NASDAQ: GDTC), a Singapore-based clinical stage biopharmaceutical company...
AEON Biopharma Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
ALISO VIEJO, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a...
Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Convertible Senior Notes
SAN CARLOS, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today...
J-Star Holding Co., Ltd. Highlights Capital Initiatives to Fund Planned U.S. Expansion for Drone Frame Manufacturing in Houston, Texas
HOUSTON, Oct. 09, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (NASDAQ: YMAT) (“J-Star” or the “Company”), an advanced composite...
NurExone Advances Optic Nerve Injury Program Toward Larger-Animal Study, Following Positive Preclinical Results
Preclinical Results at Sheba Medical Center Demonstrate Retinal Recovery with NurExone’s Exosome-based Lead CandidateTORONTO and HAIFA, Israel, Oct. 09, 2026...
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization DALLAS, TX, Oct....
MESA LABS DECLARES QUARTERLY DIVIDEND
Lakewood, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today...
RadiusXR and Topcon Healthcare Inc. Introduce InspirePRO: The New Standard in Visual Field Testing
RadiusXR and Topcon Healthcare, Inc. unveil InspirePRO at AAO: the full measurement range expertly engineered into a lightweight wearable experience....
Metro ENT Joins National Breathe Free Network, Beginning Its Next Chapter of ENT Care in the Dallas Area
Partnership builds on Metro ENT’s established physician leadership while adding the resources and infrastructure of the National Breathe Free network.MESQUITE,...
AB Science today reports its revenues for the first half of 2026 and provides an update on its activities
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIOD...
EssilorLuxottica: Third-Quarter 2026 Revenue Conference Call Invitation
Third-Quarter 2026 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure...